GenesisCare Acquires Ten New ExacTrac Dynamic Systems for Advanced Cancer Treatment Following FDA Clearance
Brainlab to deliver 10 systems to GenesisCare in the US bringing the total investment by the international oncology provider to more than 30 systems globally
Brainlab, the digital medical technology company, announced today the planned delivery of 10 new ExacTrac Dynamic® systems to GenesisCare, offering US cancer patients and physicians access to the latest treatment technologies on the market. This follows GenesisCare’s acquisition of major integrated cancer care provider, 21st Century Oncology, increasing access to advanced cancer care for patients across US communities.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201007005309/en/
FDA-cleared ExacTrac Dynamic supports the delivery of precision radiotherapy with surface and thermal tracking combined with real-time X-Ray monitoring (Source: Brainlab)
ExacTrac Dynamic, a patient positioning and position monitoring device, received FDA 510(k) clearance in July 2020 and supports the delivery of precision radiotherapy with surface and thermal tracking combined with real-time X-Ray monitoring.